Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.
T Yokoyama, … , P Hazarika, D L Mann
T Yokoyama, … , P Hazarika, D L Mann
Published November 1, 1993
Citation Information: J Clin Invest. 1993;92(5):2303-2312. https://doi.org/10.1172/JCI116834.
View: Text | PDF
Research Article Article has an altmetric score of 6

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

  • Text
  • PDF
Abstract

To define the mechanism(s) responsible for the negative inotropic effects of tumor necrosis factor-alpha (TNF alpha) in the adult heart, we examined the functional effects of TNF alpha in the intact left ventricle and the isolated adult cardiac myocyte. Studies in both the ventricle and the isolated adult cardiac myocyte showed that TNF alpha exerted a concentration- and time-dependent negative inotropic effect that was fully reversible upon removal of this cytokine. Further, treatment with a neutralizing anti-TNF alpha antibody prevented the negative inotropic effects of TNF alpha in isolated myocytes. A cellular basis for the above findings was provided by studies which showed that treatment with TNF alpha resulted in decreased levels of peak intracellular calcium during the systolic contraction sequence; moreover, these findings did not appear to be secondary to alterations in the electrophysiological properties of the cardiac myocyte. Further studies showed that increased levels of nitric oxide, de novo protein synthesis, and metabolites of the arachidonic acid pathway were unlikely to be responsible for the TNF alpha-induced abnormalities in contractile function. Thus, these studies constitute the initial demonstration that the negative inotropic effects of TNF alpha are the direct result of alterations in intracellular calcium homeostasis in the adult cardiac myocyte.

Authors

T Yokoyama, L Vaca, R D Rossen, W Durante, P Hazarika, D L Mann

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1977 Total
Citations: 6 5 6 6 8 12 8 9 7 8 6 5 11 9 19 18 5 19 25 26 27 24 28 43 35 34 28 31 27 35 18 3 1 552
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2023 (6)

Title and authors Publication Year
Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications.
Galeone A, Grano M, Brunetti G
International journal of molecular sciences 2023
Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease.
Weber BN, Giles JT, Liao KP
Nature reviews. Rheumatology 2023
CRAT links cholesterol metabolism to innate immune responses in the heart.
Mao H, Angelini A, Li S, Wang G, Li L, Patterson C, Pi X, Xie L
Nature metabolism 2023
Levosimendan in the Treatment of Patients with Severe Septic Cardiomyopathy.
Tsolaki V, Zakynthinos GE, Papanikolaou J, Vazgiourakis V, Parisi K, Fotakopoulos G, Makris D, Zakynthinos E
2023
Colchicine in atrial fibrillation: are old trees in bloom?
Zhan Y, Yue H, Zhao X, Tang J, Wu Z
Frontiers in physiology 2023
Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms.
Xiao Y, Powell DW, Liu X, Li Q
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2023

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 23 patents
Referenced in 1 clinical guideline sources
99 readers on Mendeley
See more details